34 units of semaglutide & Tirzepatide Dosing Guide: mg to Chart Semaglutide 5mg/ml dosage chart: complete

The FDA has approved the first oral GLP-1 for weight loss

Fasting is a practice that has endured centuries

Expert hormone replacement therapy, medical weight loss, NAD+ & peptide therapy

Choosing glucose-lowering medication for patients with indicators of high risk or established ASCVD, CKD, or HF

Last week, Eli Lillys orforglipron has become the first oral, non-peptide GLP-1 receptor agonist to clear a Phase 3 trial, showing strong efficacy in reducing A1C (up to 1.6%) and body weight (up to 7.9%) in people with type 2 diabetes

These medications would need to be taken long term and the population being treated will be older than the traditional weight management patient